Peter Baker1, Shari L Dworkin2, Sengfah Tong3, Ian Banks4, Tim Shand5, Gavin Yamey6. 1. Global Action on Men's Health, Brighton, England . 2. Department of Social and Behavioral Sciences, University of California, San Francisco, United States of America (USA). 3. Department of Family Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia . 4. European Men's Health Forum, Brussels, Belgium . 5. Sonke Gender Justice, Cape Town, South Africa . 6. Evidence to Policy initiative (E2Pi), Global Health Group, University of California, San Francisco, 50 Beale Street (Suite 1200), Box 1224, San Francisco, CA 94105, USA .
In most parts of the world, health outcomes among boys and men continue to be
substantially worse than among girls and women, yet this gender-based disparity in
health has received little national, regional or global acknowledgement or attention
from health policy-makers or health-care providers. Including both women and men in
efforts to reduce gender inequalities in health as part of the post-2015 sustainable
development agenda would improve everyone’s health and well-being.That men tend to be in worse health than women has now been made clear by robust evidence
from various sources. The Global Burden of Disease study led by the Institute for Health
Metrics and Evaluation in 2010 (GBD 2010 study) showed that throughout the period from
1970 to 2010, women had a longer life expectancy than men. Over that 40-year period, female life expectancy at birth
increased from 61.2 to 73.3 years, whereas male life expectancy rose from
56.4 to 67.5 years. These figures indicate that the gap in life expectancy
at birth widened between the sexes to men’s disadvantage over those 40 years.By 2010, on the whole women were outliving men by an average of almost six years. In the
region with the lowest life expectancy at birth − central sub-Saharan Africa
− men were living 5.3 years less than women on average. Eastern Europe
showed the biggest difference in life expectancy between men and women: women in the
Russian Federation were outliving men by an average of 11.6 years. According to
the Global health 2035 report, published in the Lancet
in 2013, in countries classified as “least developed” and “less
developed” by the United Nations adult mortality fell faster among women than
among men between 1992 and 2012.
Explaining the gender gap
In many societies, men generally enjoy more opportunities, privileges and power than
women, yet these multiple advantages do not translate into better health outcomes.
What explains this gender disparity? According to the WHO European Region’s
review of the social determinants of health, chaired by Sir Michael Marmot,
men’s poorer survival rates “reflect several factors – greater
levels of occupational exposure to physical and chemical hazards, behaviours
associated with male norms of risk-taking and adventure, health behaviour paradigms
related to masculinity and the fact that men are less likely to visit a doctor when
they are ill and, when they see a doctor, are less likely to report on the symptoms
of disease or illness”.How much more likely to die are men than women as a result of risk-taking behaviours?
In 2010, 3.14 million men − as opposed to 1.72 million women − died
from causes linked to excessive alcohol use. For many men, excessive consumption of alcohol is
linked to notions of masculinity. For example, a study of men in the Russian
Federation showed that heavy drinking of strong spirits “elevates or
maintains a man’s status in working-class social groups by facilitating
access to power associated with the hegemonic ideal of the real working
man”. Of 67 risk
factors and risk factor clusters identified in the GBD 2010 study, 60 were
responsible for more male than female deaths and the top 10 risk factors were all
more common in men.In many countries, research suggests that women are more likely than men to use
health services, although this disparity may reflect women’s increased use of
services during their reproductive years. For example, in England in 2008 and 2009, women aged 15 to
80 years had significantly more consultations with general practitioners than men;
the biggest gender gap was noted in the 20- to 44-year age group. In a Lithuanian study of
middle-aged university employees, women were found to be significantly more likely
than men to get regular dental check-ups.Several recent studies in Malawi, South Africa, Uganda and Zimbabwe suggest that
notions of masculinity not only increase the risk of infection with the human
immunodeficiency virus (HIV), but they also inhibit men from getting tested for HIV,
coming to terms with their HIV-positive status, taking instructions from nurses, and
engaging in health-enabling behaviours. Cornell et al. have argued that we have a “blind
spot” when it comes to men and antiretroviral therapy (ART) in Africa. These
researchers note, for example, that disproportionately fewer men than women access
ART across Africa, that men start ART later in the disease course than women, and
that men are more likely than women to interrupt treatment and be lost to
follow-up.Finally, the highly gendered nature of employment in all societies translates into
men being more exposed to occupationally related morbidity and mortality than women.
In 2010, almost 750 000 men died from occupationally related causes, as
opposed to just over 102 000 women. In Europe, 95% of fatal accidents and 76% of non-fatal
accidents at the workplace are experienced by men. In the United States of America, the occupations with
the highest risk of fatal occupational injury, such as mining, agriculture and
fishing, employ far more men than women.
Policy silence at global health institutions
As Hawkes & Buse recently noted, the gender disparities noted earlier are not
properly addressed in the health policies and programmes of the major global health
institutions, including WHO.
Policy-makers tend to assume that gendered approaches to health improvement are
primarily or exclusively about women rather than about both sexes, a position also
adopted by most national governments. To the best of our knowledge, only three
countries – Australia, Brazil and Ireland – have to date attempted to
address men’s burden of ill health through the adoption of national,
male-centred strategies.Compounding this neglect by policy-makers are negative stereotypes of men on the part
of many health-care providers. For instance, some assume that men are largely
disinterested in their health – an attitude that can, in turn, discourage men
from engaging with health services. Barker et al. have noted that “health programs
often view men mainly as oppressors – self-centred, disinterested, or violent
– instead of as complex subjects whose behaviours are influenced by gender
and sexual norms”.Any serious effort to improve public health must include attention to the health
needs of both sexes and responsiveness to the differences between them. Attention to
men’s and women’s health will be particularly important in tackling
the global epidemic of noncommunicable diseases, which are likely to affect more men
than women and to affect men at a younger age.Taking action is not just a matter of equity; it is also a matter of economics. For
example, men’s underuse of primary care services in Denmark results in their
use of more expensive hospital services instead, while men’s premature mortality and morbidity
cost the United States economy alone an estimated 479 billion United States dollars
annually.
Policy targets and effective interventions
White et al. have argued that public and policy action to improve men’s health
should have three targets. The
first is schools, where stereotypes about masculinity can be challenged. The second
is the promotion of men’s health and well-being in the workplace. A third
crucial area for policy is to target health services and health promotion towards
marginalized men, men from minority populations, men in prison populations and men
who have sex with men – all of whom have a higher burden of disease and early
death than other men.Three types of intervention targeting men have emerged in recent years –
outreach, partnership and gender transformation – and there is now evidence
to support all three approaches. Interventions in high-income countries (e.g.
Australia, the United States and countries of western Europe) have generally
involved outreach efforts aimed at men in pubs and bars, sports clubs, barber shops,
schools and the workplace, with a focus on weight loss, smoking cessation and other
lifestyle changes. In a recent randomized controlled trial of a gender-sensitized
weight loss and healthy living programme for overweight or obese male soccer fans at
13 Scottish professional soccer clubs, the intervention led to significant weight
loss.A second approach involves partnering with men to improve women’s and
children’s health. For example, research in Ghana has shown that child
vaccination programmes designed to involve fathers (not just mothers) in decisions
about their children's use of preventive health services may increase timely
immunization coverage levels.
Similarly, systematic reviews of studies conducted in low- and middle-income
countries have shown the benefits of engaging male partners in decisions about
reproductive and sexual health, including family planning.A third approach, which is being increasingly supported by evidence from randomized
controlled trials and other types of studies, is to support interventions aimed at
gender transformation. These aim to reshape male gender roles in ways that lead to
more equitable relationships between women and men. Such interventions can increase
protective sexual behaviours, prevent intimate partner violence, modify inequitable
attitudes linked to gender, and reduce sexually transmitted infections.
A global men’s health movement
WHO’s Regional Office for Europe has made a bold commitment to
“addressing the impact of gender on men's health and involving men in
achieving gender equity in the WHO European Region through WHO programmes or direct
support to Member States”. However, it is unclear what actions the office has taken
to date or is planning for the future. In 2011, the European Commission published a
comprehensive report, The state of men’s health in
Europe, but an
action plan based on its findings has not yet been produced.Global, regional and national health and development agencies could certainly learn
from the success of civil society groups in promoting policies that target men. For
example, the South African non-profit organization Sonke Gender Justice successfully
pushed the government to add interventions targeting men within South
Africa’s national HIV strategic plan. The charity Men’s Health Forum
(England and Wales) was instrumental in persuading the government of the United
Kingdom of Great Britain and Northern Ireland to extend the national chlamydia
screening programme to cover young people of both sexes rather than primarily
women.Given the robust evidence of a “men’s health gap” and the
emerging evidence on how to close it, the next step is to move the issue higher up
on the agenda of national governments and global health institutions without
diminishing efforts to improve women’s health. A new organization, Global
Action on Men’s Health, has recently been established by men’s health
organizations around the world to advocate for national, regional and global public
health policies that take account of men as well as women.
Conclusion
The GBD 2010 study has, we hope, helped to raise awareness of the excess burden of
morbidity and mortality in men. Concerted global action to reduce this burden could
have a transformative social, health and economic impact. It is time to not only
acknowledge the benefits of such action to men, but also to recognize and measure
its potential benefits to women, children and society as a whole. Men’s
physical illness, for example, can impair the psychological health of their female
partners; when men are sick, injured or die, households and female partners suffer a
loss of income. Closing the
men’s health gap can benefit men, women and their children.
Authors: Alan White; Martin McKee; Noel Richardson; Richard de Visser; Svend Aage Madsen; Bruno C de Sousa; Richard Hogston; Witold Zatonski; Péter Makara Journal: BMJ Date: 2011-11-29
Authors: Haidong Wang; Laura Dwyer-Lindgren; Katherine T Lofgren; Julie Knoll Rajaratnam; Jacob R Marcus; Alison Levin-Rector; Carly E Levitz; Alan D Lopez; Christopher J L Murray Journal: Lancet Date: 2012-12-15 Impact factor: 79.321
Authors: Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish Journal: Lancet Date: 2012-12-15 Impact factor: 79.321
Authors: Kate Hunt; Sally Wyke; Cindy M Gray; Annie S Anderson; Adrian Brady; Christopher Bunn; Peter T Donnan; Elisabeth Fenwick; Eleanor Grieve; Jim Leishman; Euan Miller; Nanette Mutrie; Petra Rauchhaus; Alan White; Shaun Treweek Journal: Lancet Date: 2014-01-21 Impact factor: 79.321
Authors: Carla F Justiniano; Larissa K Temple; Alex A Swanger; Zhaomin Xu; Jenny R Speranza; Christina Cellini; Rabih M Salloum; Fergal J Fleming Journal: Dis Colon Rectum Date: 2018-11 Impact factor: 4.585
Authors: Hrishikesh Chakraborty; Robert Neal Axon; Jordan Brittingham; Genevieve Ray Lyons; Laura Cole; Christine B Turley Journal: Health Serv Res Date: 2016-09-28 Impact factor: 3.402
Authors: Katelyn M Sileo; Elizabeth Reed; Williams Kizito; Jennifer A Wagman; Jamila K Stockman; Rhoda K Wanyenze; Harriet Chemusto; William Musoke; Barbara Mukasa; Susan M Kiene Journal: Cult Health Sex Date: 2018-11-13
Authors: Linda-Gail Bekker; George Alleyne; Stefan Baral; Javier Cepeda; Demetre Daskalakis; David Dowdy; Mark Dybul; Serge Eholie; Kene Esom; Geoff Garnett; Anna Grimsrud; James Hakim; Diane Havlir; Michael T Isbell; Leigh Johnson; Adeeba Kamarulzaman; Parastu Kasaie; Michel Kazatchkine; Nduku Kilonzo; Michael Klag; Marina Klein; Sharon R Lewin; Chewe Luo; Keletso Makofane; Natasha K Martin; Kenneth Mayer; Gregorio Millett; Ntobeko Ntusi; Loyce Pace; Carey Pike; Peter Piot; Anton Pozniak; Thomas C Quinn; Jurgen Rockstroh; Jirair Ratevosian; Owen Ryan; Serra Sippel; Bruno Spire; Agnes Soucat; Ann Starrs; Steffanie A Strathdee; Nicholas Thomson; Stefano Vella; Mauro Schechter; Peter Vickerman; Brian Weir; Chris Beyrer Journal: Lancet Date: 2018-07-20 Impact factor: 79.321